TO BE PUBLISHED April 2020
This conference will consider the next steps for diagnostics and pathology in England - looking at supporting innovation, rolling out networks, and developing standards.
The conference will provide a timely opportunity to discuss the use of technology, artificial intelligence, and genomics to improve the diagnosis of disease.
It will also be an opportunity to discuss the Medicines and Medical Devices Bill announced in the Queen’s Speech, which outlines aims to develop advanced therapies and rapid diagnostics in the UK through:
- Streamlining regulation;
- Support for research and the life sciences sector; and
- Making it easier for hospitals to trial new personalised medicines.
We also expect discussion on the next steps for meeting the commitment in the NHS Long Term Plan to implement pathology networks across England by 2021 and diagnostic imaging networks by 2023.
The agenda includes keynote addresses from:
- Mirella Marlow, Programme Director, Centre for Health Technology Evaluation, NICE;
- Professor Jo Martin, President, Royal College of Pathologists; and
- Professor Sir Mark Caulfield, Chief Scientist, Genomics England.
Further speakers include: Dr Saoirse Dolly, Guy’s and St Thomas’ NHS Foundation Trust; Professor Carl Heneghan, University of Oxford; Anna Jewell, Pancreatic Cancer UK; Dr Michael Messenger, University of Leeds; The Leeds Centre for Personalised Medicine and NIHR Leeds MedTech and In-Vitro Diagnostic Co-Operative; Professor Dion Morton, University of Birmingham and West Midlands Genomic Medicine Centre; Dr Steven Powell, Rutherford Diagnostics; Dr Caroline Rubin, Royal College of Radiologists; Dr Darren Treanor, Leeds Teaching Hospitals NHS Trust; Northern Pathology Imaging Co-operative and Royal College of Pathologists; and Luella Trickett, Director, Values & Access, Association of British Healthcare Industries.
The agenda in summary
- Rolling out imaging and pathology networks:
- Integration, utilising shared resources and the role of technology; and
- Consolidating pathology services, and supporting staff recruitment, development, and retention.
- Improving diagnostic times for cancer and learning from Rapid Diagnostic Centres;
- Accelerating the diagnostic process - research funding, developing standards, and upgrading infrastructure;
- Innovation in diagnostics and pathology - utilising data and artificial intelligence, encouraging uptake, and developing personalised treatments; and
- Evaluating diagnostic technologies and assessing barriers to adoption.
Engagement with policy officials at this conference
This Westminster Health Forum conference has attracted strong interest from policymakers. It will be an opportunity for stakeholders to engage with officials who have reserved places representing: DHSC; MHRA; Office for Life Sciences; Cabinet Office; BEIS; DIT; and the Welsh Government.
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF